Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.
Mebias Discovery holds a game-changing platform to discover next generation.
Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
BRAINBox provides objective evidence of injury and prediction of patient recovery.
NeuralGalaxy is a brain science company which is devoted to solve brain disorders.
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.
Regenacy Pharmaceuticals Provides Healthcare Services.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Cantai Therapeutics operates as a developer of drug candidates.
Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
CorneaSense is a medtech startup developing a non-invasive eye sensor to measure ocular hydration for early disease detection.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
BioVenture has invested in 273 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, LB Pharmaceuticals received $150.0M in a Post-IPO Equity round. BioVenture's total known invested capital is $1.3B.
BioVenture's average investment size is $28.7M across its portfolio of 273 companies.
Recent BioVenture portfolio additions include Navrogen, Rapafusyn Pharmaceuticals, Renovacor, AnaCardio, Nionyx Bio. These companies were founded in 2020 or later.